In Nasal congestion (blocked nose) Xylorex Nasal Spray clears a blocked nose caused by common cold or allergies such as hay fever. This reduces congestion and helps in easy breathing. Xylorex Nasal Spray contains a moisturizing agent that gives relief from dryness in the nose. It should be used as prescribed and should not be taken for more than seven days in a row (preferably less). It is advisable to talk to your doctor if your symptoms do not improve after taking Xylorex Nasal Spray. Regular steam inhalation with few drops of eucalyptus can give you relief from a blocked nose.
No interaction found/established
Xylorex Nasal Spray may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Xylorex Nasal Spray is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
No interaction found/established
No interaction found/established
No interaction found/established
If you miss a dose of Xylorex Nasal Spray, use it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More